Effects of Frailty on Outcomes and 30-day Readmissions After Surgical Mitral Valve Replacement

被引:1
|
作者
Iyengar, Amit
Goel, Nicholas
Kelly, John J.
Han, Jason
Brown, Chase R.
Khurshan, Fabliha
Chen, Zehang
Desai, Nimesh
机构
[1] Univ Penn, Dept Surg, Div Cardiac Surg, Philadelphia, PA 19104 USA
[2] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA
来源
ANNALS OF THORACIC SURGERY | 2020年 / 109卷 / 04期
关键词
SURGERY; TRANSCATHETER; IMPACT; SURVIVAL; REPAIR;
D O I
10.1016/j.athoracsur.2016.10.087
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. Frailty is increasingly recognized as an important prognostic marker in surgical populations. The effects of frailty on outcomes after mitral valve replacement (MVR) is less clear given the inherent complexity of this patient population. We evaluated the influences of frailty on outcomes and readmission rates after MVR. Methods. Adult patients undergoing isolated MVR were queried from the National Readmissions Database from 2010 to 2014. Frailty was defined using the Johns Hopkins Adjusted Clinical Groups frailty-defining diagnoses indicator, a validated instrument developed for use in health administrative data. Multivariable logistic regression was used to determine hospital- and patientlevel risk factors for readmission, postoperative complications, and death. Results. Among 50,410 patients who underwent MVR, 7.9% met frailty criteria. Frail patients were more likely to be older, have nonprivate insurance, an index admission from the emergency department, and teaching hospital care (all P < .001). Frail patients had significantly more postoperative complications (77% vs 47%, P < .001), more discharges to a facility (50% vs 21%, P < .001), and higher in-hospital mortality (12% vs 4%, P < .001). Index hospitalization costs were almost doubled in frail patients, and of those who survived to discharge, 30-day readmissions were more frequent (28% vs 20%, P < .001). Frailty independently increased the risk of index hospitalization composite complications (adjusted odds ratio [AOR], 3.28; 95% confidence interval [CI], 2.61-4.12), in-hospital mortality (AOR, 2.35; 95% CI, 1.90-2.92), and 30-day readmission (AOR, 1.47; 95% CI, 1.20-1.78). Conclusions. Frailty is an independent predictor of morbidity, death, and increased costs after MVR. Frailty metrics should be increasingly understood among patients requiring mitral valve intervention as percutaneous approaches for intervention become increasingly used. (C) 2020 by The Society of Thoracic Surgeons
引用
收藏
页码:1120 / 1126
页数:7
相关论文
共 50 条
  • [31] Outcomes and Predictors of 30-Day Readmissions for Hyperthyroidism: A Nationwide Study
    Salim, Michael
    El-Amir, Zain
    Kichloo, Asim
    Wani, Farah
    Edigin, Ehizogie
    Shaka, Hafeez
    ENDOCRINOLOGY AND METABOLISM, 2021, 36 (06) : 1307 - 1311
  • [32] Trends and Outcomes of 30-day Readmissions After Left Ventricular Assist Device Implantation
    Ueyama, Hiroki
    Malik, Aaqib H.
    Kuno, Toshiki
    Yokoyama, Yujiro
    Briasoulis, Alexandros
    CIRCULATION, 2020, 142
  • [33] 30-Day Readmissions of Percutaneous Mechanical Aspiration of Tricuspid Valve Vegetation
    Hussain, Bilal
    Boyer-Sprouse, Cody Morgan
    Akhtar, Yasir
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 82 (17) : B277 - B277
  • [34] 30-Day Outcomes Following Transfemoral Transseptal Transcatheter Mitral Valve Replacement Intrepid TMVR Early Feasibility Study Results
    Zahr, Firas
    Song, Howard K.
    Chadderdon, Scott M.
    Gada, Hemal
    Mumtaz, Mubashir
    Byrne, Timothy
    Kirshner, Merick
    Bajwa, Tanvir
    Weiss, Eric
    Kodali, Susheel
    George, Isaac
    Heiser, John
    Merhi, William M.
    Thaden, Jeremy J.
    Zhang, Angie
    Lim, D. Scott
    Reardon, Michael J.
    Adams, David H.
    Mack, Michael J.
    Leon, Martin B.
    JACC-CARDIOVASCULAR INTERVENTIONS, 2022, 15 (01) : 80 - 89
  • [35] Utility of 90-Day Mortality vs 30-Day Mortality as a Quality Metric for Transcatheter and Surgical Aortic Valve Replacement Outcomes
    Hirji, Sameer
    McGurk, Siobhan
    Kiehm, Spencer
    Ejiofor, Julius
    Ramirez-Del Val, Fernando
    Kolkailah, Ahmed A.
    Berry, Natalia
    Sobieszczyk, Piotr
    Pelletier, Marc
    Shah, Pinak
    O'Gara, Patrick
    Kaneko, Tsuyoshi
    JAMA CARDIOLOGY, 2020, 5 (02) : 156 - 165
  • [36] Cardiovascular Outcomes of Frailty in Surgical Aortic Valve Replacement and Its Impact on Readmissions: A Nationwide Readmission Analysis
    Sattar, Yasar
    Patel, Nirav
    Titus, Anoop
    Patel, Neel
    Pandya, Krutarth
    Khan, Muhammad
    Alraies, M. Chadi
    Daggubati, Ramesh
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 80 (12) : B182 - B182
  • [37] Carotid Body Tumor: 30-Day Outcomes After Surgical Intervention
    Chaney, Michael
    Coster, Samuel J.
    Ko, Alexander
    Shebrain, Saad
    Ryan, Jason
    JOURNAL OF VASCULAR SURGERY, 2024, 79 (04) : 27S - 28S
  • [38] Association of the Modified Frailty Index With 30-Day Surgical Readmission
    Wahl, Tyler S.
    Graham, Laura A.
    Hawn, Mary T.
    Richman, Joshua
    Hollis, Robert H.
    Jones, Caroline E.
    Copeland, Laurel A.
    Burns, Edith A.
    Itani, Kamal M.
    Morris, Melanie S.
    JAMA SURGERY, 2017, 152 (08) : 749 - 757
  • [39] Disparities in 30-Day Readmissions After Total Hip Arthroplasty
    Oronce, Carlos Irwin A.
    Shao, Hui
    Shi, Lizheng
    MEDICAL CARE, 2015, 53 (11) : 924 - 930
  • [40] ASSOCIATION OF FRAILTY AND OUTCOMES FOLLOWING TRANSCATHETER MITRAL VALVE REPLACEMENT
    Liu, Victor
    Oh, Gahee
    Kim, Dae Hyun
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 77 (18) : 1746 - 1746